FDA Approves World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults

The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It

A New Method of COVID-19 Detection

Researchers have found that wrist-worn health devices can be combined with machine learning to detect COVID-19 infections as early as two days before symptoms appear, and this could open the door to applying the use of wearable health tech for the early detection of other infectious diseases. The “COVI-GAPP” study was conducted by researchers from

GSK Announces Positive Data for its Respiratory Syncytial Virus Vaccine Candidate for Older Adults 

JoinAStudy.ca Investigators Dr. Peter Dzongowski, Dr. Michael Jones and Dr. Sean Peterson were all recently involved in GSK trial AReSVi 006, evaluating a vaccine candidate for Respiratory Syncytial Virus (RSV). Recruitment was highly successful for all three investigators, whose work has helped lead to the first RSV vaccine candidate to show statistically significant and clinically

Why Bilingualism Could Be Good for Your Brain

Researchers have found that bilingualism can slow down and mitigate the course of age-related changes in the human brain. The study is authored by scientists from the Institute of Cognitive Neuroscience in Moscow, Vita-Salute San Raffaele University in Milan and Northumbria University in Newcastle.   A sample of cognitively healthy senior (60+ years of age) bilingual

Gupta, OCFP

Video Presentation by Dr. Anil Gupta – Treating COVID-19 Infection Early

JoinAStudy.ca Investigator Dr. Anil Gupta was recently asked to assist in the presentation of strategies for preventing COVID progression and transmission in the outpatient setting, including the latest therapeutic developments. This effort was supported by an educational grant from Merck Sharp & Dohme Corp. The presentation linked below will define the sub-populations that are most